A citation-based method for searching scientific literature

Anastasia Zekeridou, Vanda A Lennon. Mayo Clin Proc 2019
Times Cited: 24







List of co-cited articles
139 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature.
S Cuzzubbo, F Javeri, M Tissier, A Roumi, C Barlog, J Doridam, C Lebbe, C Belin, R Ursu, A F Carpentier. Eur J Cancer 2017
223
29

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
Julie R Brahmer, Christina Lacchetti, Bryan J Schneider, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau, Marc S Ernstoff, Jennifer M Gardner, Pamela Ginex,[...]. J Clin Oncol 2018
29

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Maarten J Titulaer, Lindsey McCracken, Iñigo Gabilondo, Thaís Armangué, Carol Glaser, Takahiro Iizuka, Lawrence S Honig, Susanne M Benseler, Izumi Kawachi, Eugenia Martinez-Hernandez,[...]. Lancet Neurol 2013
25

Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.
Tanya J Williams, David R Benavides, Kelly-Ann Patrice, Josep O Dalmau, Alexandre Leon Ribeiro de Ávila, Dung T Le, Evan J Lipson, John C Probasco, Ellen M Mowry. JAMA Neurol 2016
160
20

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.
Anastasia Zekeridou, Thomas Kryzer, Yong Guo, Anhar Hassan, Vanda Lennon, Claudia F Lucchinetti, Sean Pittock, Andrew McKeon. Neurology 2019
17
29

Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.
Steven Vernino, Paul Tuite, Charles H Adler, James F Meschia, Bradley F Boeve, Peter Boasberg, Joseph E Parisi, Vanda A Lennon. Ann Neurol 2002
126
20

Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis.
Caleigh Mandel-Brehm, Divyanshu Dubey, Thomas J Kryzer, Brian D O'Donovan, Baouyen Tran, Sara E Vazquez, Hannah A Sample, Kelsey C Zorn, Lillian M Khan, Ian O Bledsoe,[...]. N Engl J Med 2019
62
20

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.
Divyanshu Dubey, William S David, Kerry L Reynolds, Donald F Chute, Nathan F Clement, Justine V Cohen, Donald P Lawrence, Meghan J Mooradian, Ryan J Sullivan, Amanda C Guidon. Ann Neurol 2020
42
20

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies.
Divyanshu Dubey, William S David, Anthony A Amato, Kerry L Reynolds, Nathan F Clement, Donald F Chute, Justine V Cohen, Donald P Lawrence, Meghan J Mooradian, Ryan J Sullivan,[...]. Neurology 2019
53
20

Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes.
Elia Sechi, Svetomir N Markovic, Andrew McKeon, Divyanshu Dubey, Teerin Liewluck, Vanda A Lennon, A Sebastian Lopez-Chiriboga, Christopher J Klein, Michelle Mauermann, Sean J Pittock,[...]. Neurology 2020
29
20

Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.
Eoin P Flanagan, Shannon R Hinson, Vanda A Lennon, Boyan Fang, Allen J Aksamit, P Pearse Morris, Eati Basal, Josephe A Honorat, Nora B Alfugham, Jenny J Linnoila,[...]. Ann Neurol 2017
160
20

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
F Graus, J Y Delattre, J C Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, P Sillevis Smitt, Ch Vedeler, J J G M Verschuuren,[...]. J Neurol Neurosurg Psychiatry 2004
980
16

Antibody-Mediated Encephalitis.
Josep Dalmau, Francesc Graus. N Engl J Med 2018
333
16

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.
Divyanshu Dubey, Sean J Pittock, Cecilia R Kelly, Andrew McKeon, Alfonso Sebastian Lopez-Chiriboga, Vanda A Lennon, Avi Gadoth, Carin Y Smith, Sandra C Bryant, Christopher J Klein,[...]. Ann Neurol 2018
196
16

Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
Thaís Armangue, Marianna Spatola, Alexandru Vlagea, Simone Mattozzi, Marc Cárceles-Cordon, Eloy Martinez-Heras, Sara Llufriu, Jordi Muchart, María Elena Erro, Laura Abraira,[...]. Lancet Neurol 2018
177
16

Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues.
E P Flanagan, A McKeon, V A Lennon, J Kearns, B G Weinshenker, K N Krecke, M Matiello, B M Keegan, B Mokri, A J Aksamit,[...]. Neurology 2011
99
16

Paraneoplastic syndromes involving the nervous system.
Robert B Darnell, Jerome B Posner. N Engl J Med 2003
612
16

Antibody-associated CNS syndromes without signs of inflammation in the elderly.
Domingo Escudero, Mar Guasp, Helena Ariño, Carles Gaig, Eugenia Martínez-Hernández, Josep Dalmau, Francesc Graus. Neurology 2017
47
16

Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.
Andrew L Mammen, Arun Rajan, Katherine Pak, Tanya Lehky, Livia Casciola-Rosen, Renee N Donahue, Lauren M Lepone, Anastasia Zekeridou, Sean J Pittock, Raffit Hassan,[...]. Ann Rheum Dis 2019
40
16

Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan.
Shigeaki Suzuki, Nobuhisa Ishikawa, Fumie Konoeda, Nobuhiko Seki, Satoshi Fukushima, Kikuko Takahashi, Hisashi Uhara, Yoshikazu Hasegawa, Shinichiro Inomata, Yasushi Otani,[...]. Neurology 2017
188
16

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.
Alberto Vogrig, Marine Fouret, Bastien Joubert, Géraldine Picard, Véronique Rogemond, Anne-Laurie Pinto, Sergio Muñiz-Castrillo, Maxime Roger, Judith Raimbourg, Charles Dayen,[...]. Neurol Neuroimmunol Neuroinflamm 2019
51
16

CRMP5-IgG-Associated Paraneoplastic Myelopathy With PD-L1 Inhibitor Therapy.
Amy Kunchok, Anastasia Zekeridou, Sean Pittock. JAMA Neurol 2020
12
33

Clinical analysis of anti-Ma2-associated encephalitis.
Josep Dalmau, Francesc Graus, Alberto Villarejo, Jerome B Posner, Deborah Blumenthal, Brian Thiessen, Albert Saiz, Patricio Meneses, Myrna R Rosenfeld. Brain 2004
367
16

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Michael A Postow, Robert Sidlow, Matthew D Hellmann. N Engl J Med 2018
16

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.
Lisa Ann Gerdes, Kathrin Held, Eduardo Beltrán, Carola Berking, Jörg C Prinz, Andreas Junker, Julia K Tietze, Birgit Ertl-Wagner, Andreas Straube, Tania Kümpfel,[...]. Ann Neurol 2016
58
16

PD-1 Inhibitor-associated Myopathies: Emerging Immune-mediated Myopathies.
Teerin Liewluck, Justin C Kao, Michelle L Mauermann. J Immunother 2018
82
16

Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.
Justin C Kao, Bing Liao, Svetomir N Markovic, Christopher J Klein, Elie Naddaf, Nathan P Staff, Teerin Liewluck, Julie E Hammack, Paola Sandroni, Heidi Finnes,[...]. JAMA Neurol 2017
146
16

Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer.
Yuki Nakatani, Natsuki Tanaka, Tomomi Enami, Seigo Minami, Tomoko Okazaki, Kiyoshi Komuta. Case Rep Neurol 2018
30
16

Paraneoplastic neuronal intermediate filament autoimmunity.
Eati Basal, Nicholas Zalewski, Thomas J Kryzer, Shannon R Hinson, Yong Guo, Divyanshu Dubey, Eduardo E Benarroch, Claudia F Lucchinetti, Sean J Pittock, Vanda A Lennon,[...]. Neurology 2018
22
18

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
I Puzanov, A Diab, K Abdallah, C O Bingham, C Brogdon, R Dadu, L Hamad, S Kim, M E Lacouture, N R LeBoeuf,[...]. J Immunother Cancer 2017
791
16

DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.
William Oliver Tobin, Vanda A Lennon, Lars Komorowski, Christian Probst, Stacey Lynn Clardy, Allen J Aksamit, Juan Pablo Appendino, Claudia F Lucchinetti, Joseph Y Matsumoto, Sean J Pittock,[...]. Neurology 2014
121
16


Aquaporin-4 autoantibodies in a paraneoplastic context.
Sean J Pittock, Vanda A Lennon. Arch Neurol 2008
134
12

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
Sean J Pittock, Achim Berthele, Kazuo Fujihara, Ho Jin Kim, Michael Levy, Jacqueline Palace, Ichiro Nakashima, Murat Terzi, Natalia Totolyan, Shanthi Viswanathan,[...]. N Engl J Med 2019
233
12

Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy.
Divyanshu Dubey, Jeffrey Britton, Andrew McKeon, Avi Gadoth, Anastasia Zekeridou, Sebastian A Lopez Chiriboga, Michelle Devine, Jane H Cerhan, Katie Dunlay, Jessica Sagen,[...]. Ann Neurol 2020
39
12

A clinical approach to diagnosis of autoimmune encephalitis.
Francesc Graus, Maarten J Titulaer, Ramani Balu, Susanne Benseler, Christian G Bien, Tania Cellucci, Irene Cortese, Russell C Dale, Jeffrey M Gelfand, Michael Geschwind,[...]. Lancet Neurol 2016
12

The importance of early immunotherapy in patients with faciobrachial dystonic seizures.
Julia Thompson, Mian Bi, Andrew G Murchison, Mateusz Makuch, Christian G Bien, Kon Chu, Pue Farooque, Jeffrey M Gelfand, Michael D Geschwind, Lawrence J Hirsch,[...]. Brain 2018
136
12

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.
Avi Gadoth, Sean J Pittock, Divyanshu Dubey, Andrew McKeon, Jeff W Britton, John E Schmeling, Aurelia Smith, Amy L Kotsenas, Robert E Watson, Daniel H Lachance,[...]. Ann Neurol 2017
107
12


Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.
Douglas B Johnson, Ali Manouchehri, Alexandra M Haugh, Henry T Quach, Justin M Balko, Benedicte Lebrun-Vignes, Andrew Mammen, Javid J Moslehi, Joe-Elie Salem. J Immunother Cancer 2019
106
12

Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.
Benoît Déchelotte, Sergio Muñiz-Castrillo, Bastien Joubert, Alberto Vogrig, Géraldine Picard, Véronique Rogemond, Anne-Laurie Pinto, Christine Lombard, Virginie Desestret, Nicole Fabien,[...]. Neurol Neuroimmunol Neuroinflamm 2020
24
12

Clinical manifestations of the anti-IgLON5 disease.
Carles Gaig, Francesc Graus, Yarko Compta, Birgit Högl, Luis Bataller, Norbert Brüggemann, Caroline Giordana, Anna Heidbreder, Katya Kotschet, Jan Lewerenz,[...]. Neurology 2017
132
12

Epidemiology of paraneoplastic neurological syndromes: a population-based study.
Alberto Vogrig, Gian Luigi Gigli, Samantha Segatti, Elisa Corazza, Alessandro Marini, Andrea Bernardini, Francesca Valent, Martina Fabris, Francesco Curcio, Francesco Brigo,[...]. J Neurol 2020
27
12

Tumor-specific killer cells in paraneoplastic cerebellar degeneration.
M L Albert, J C Darnell, A Bender, L M Francisco, N Bhardwaj, R B Darnell. Nat Med 1998
324
12

A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes.
AlexanderJ Gill, Michael A Perez, Christopher M Perrone, Charles J Bae, Amy A Pruitt, Eric Lancaster. J Neuroimmunol 2019
20
15

Paraneoplastic neurological syndromes.
Jérôme Honnorat, Jean-Christophe Antoine. Orphanet J Rare Dis 2007
150
12

Paraneoplastic neurological syndromes.
F Leypoldt, K-P Wandinger. Clin Exp Immunol 2014
73
12

Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature.
L Spain, G Walls, M Julve, K O'Meara, T Schmid, E Kalaitzaki, S Turajlic, M Gore, J Rees, J Larkin. Ann Oncol 2017
139
12

Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Anastasia Zekeridou, Masoud Majed, Ioannis Heliopoulos, Vanda A Lennon. Thorac Cancer 2019
22
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.